Dermapharm Holding SE
DMPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $172 | $62 | $216 | $293 |
| Dep. & Amort. | $87 | $102 | $95 | $55 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$18 | $9 | -$4 | -$46 |
| Other Non-Cash | -$39 | $46 | -$19 | -$51 |
| Operating Cash Flow | $201 | $219 | $289 | $250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38 | -$42 | -$39 | -$61 |
| Net Acquisitions | $0 | -$389 | -$70 | -$23 |
| Inv. Purchases | -$0 | $0 | -$6 | -$48 |
| Inv. Sales/Matur. | $1 | $8 | $10 | $61 |
| Other Inv. Act. | $8 | $8 | $6 | -$59 |
| Investing Cash Flow | -$30 | -$415 | -$99 | -$129 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$101 | $301 | -$71 | -$26 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$47 | -$57 | -$117 | -$47 |
| Other Fin. Act. | -$60 | -$40 | -$12 | -$8 |
| Financing Cash Flow | -$209 | $205 | -$200 | -$81 |
| Forex Effect | -$0 | -$0 | -$0 | $1 |
| Net Chg. in Cash | -$37 | $8 | -$10 | $41 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $159 | $151 | $161 | $120 |
| End Cash | $121 | $159 | $151 | $161 |
| Free Cash Flow | $163 | $178 | $250 | $189 |